Hydroxychloroquine shortages ‘hit patient health’

Up to a quarter of rheumatology patients were disadvantaged in some regions, a global survey suggests
Medicom Staff writer
coronavirus particles

AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.

Shortages of hydroxychloroquine and chloroquine early in the COVID-19 pandemic led to 6% of rheumatology patients on the medications being unable to obtain them, which measurably affected their health, a study shows.